News
More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...
Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...
4h
WRIC ABC 8News on MSNUVA researchers warn GLP-1 drugs may not provide long-term weight loss benefitsNew research from experts at the University of Virginia (UVA) says that GLP-1 drugs may help people lose weight, but do not ...
Low rates of retained gastric contents were seen in endoscopy patients on GLP-1 receptor agonists ( RAs), a retrospective ...
Discover how food brands can adapt to the rising GLP-1 trend. As weight-loss drugs reshape consumer habits, learn which ...
While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...
Table of Contents The Real Story Behind Your Changing Body Making Every Bite Count When You’re Eating Less Your Brain […] The ...
Estimated risk ratio was lower with GLP-1 receptor agonists for those younger than 75 years, but was no different for those aged 75 years or older ...
Popular GLP-1 drugs help many people drop tremendous amounts of weight, but the drugs fail to provide a key improvement in heart and lung function essential for long-term good health, University of ...
A major new study reveals that older adults with cancer and type 2 diabetes who take GLP-1 receptor agonist medications (GLP-1RAs) experience significantly better overall survival rates compared to ...
For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment ...
After the American Academy of Pediatrics recommended the use of certain GLP-1 weight loss drugs in January of 2023, the use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results